Welcome to our dedicated page for Charles & Colvard news (Ticker: CTHR), a resource for investors and traders seeking the latest updates and insights on Charles & Colvard stock.
Charles & Colvard, Ltd. (CTHR) generates news that spans product strategy, financing, governance, and stock listing developments, reflecting its role as a fine jewelry company focused on moissanite and lab-grown diamonds. Company press releases emphasize its identity as the original creator of lab-grown moissanite and a promoter of Made, not Mined™ above-ground gemstones and recycled precious metals, while also documenting key events that matter to investors and industry observers.
News coverage for Charles & Colvard often highlights strategic partnerships and product-related initiatives. Examples include its alliance with Ethara Capital LLC, an affiliate of Bhanderi Lab Grown Diamonds Inc., to expand its Caydia® lab-grown diamond offerings for both consumers and wholesale markets, and its exclusive strategic alliance with the International Gemological Institute (IGI) to introduce grading reports for Forever One™ moissanite gemstones and jewelry. Another notable development is its partnership with VideoShops, a social commerce network, which brings the company’s Made, not Mined™ jewelry catalog into customer-run storefronts and peer-to-peer selling environments.
Investors following CTHR news will also see regulatory and capital markets updates. The company has reported on a one-for-ten reverse stock split intended to address Nasdaq’s minimum bid price requirement, subsequent notices of non-compliance related to delayed SEC filings, and an April 2025 announcement that Nasdaq would suspend trading and delist its common stock, with the company expecting quotation on the OTC Experts Market. Additional news includes arbitration outcomes, shareholder activism and proxy-related communications, and disclosures about financing agreements such as the Convertible Secured Note Purchase Agreement with Ethara Capital LLC.
This news page allows readers to track how Charles & Colvard’s branding around Forever One™ moissanite and Caydia® lab-grown diamonds intersects with governance changes, litigation, financing, and trading status updates. Regularly reviewing CTHR news can help market participants understand both the company’s jewelry-focused initiatives and the risks and structural changes described in its public statements.
Summary not available.
Summary not available.
Charles & Colvard, Ltd. (Nasdaq: CTHR) announced on April 25, 2023, that it has regained compliance with Nasdaq's minimum bid price listing requirement. The company confirmed that as of April 20, 2023, the minimum bid price of its common stock was at least $1.00 per share for the last 10 consecutive trading days. This achievement fulfills the Listing Rule 5550(a)(2) requirement, effectively closing the compliance issue. Charles & Colvard specializes in fine jewelry, particularly lab-grown diamonds and moissanite, and operates under the motto of ethical sourcing and sustainability.
Charles & Colvard, Ltd. (Nasdaq: CTHR) will host an investor conference call on May 4, 2023, at 4:30 p.m. ET to discuss its financial results for the quarter ended March 31, 2023.
The results will be released after the market closes on the same day. Interested parties can join the call by dialing (844) 875-6912 (US) or (412) 317-6708 (international). A live webcast will also be available on the company's Investor Relations site.
A teleconference replay will be accessible until May 11, 2023. Charles & Colvard specializes in lab-grown moissanite and diamonds, promoting ethical jewelry through their innovative brands.
On April 13, 2023, Charles & Colvard (Nasdaq: CTHR) announced a strategic retail partnership with XCEL Brands' Longaberger. This collaboration will feature the Moissanite by Charles & Colvard® line on Longaberger's website. The partnership aims to align with Longaberger's community-focused brand ethos and Charles & Colvard's commitment to ethical jewelry creation using Made, Not Mined™ gems. Both companies express optimism about enhancing customer engagement through innovative sales strategies, including livestreaming. XCEL Brands is recognized for its media-driven commerce approach, further positioning this partnership to capture emerging consumer markets.
Charles & Colvard (CTHR) reported net sales of $10.4 million for the second quarter ending December 31, 2022, reflecting a 25% decline from the previous year’s $13.8 million. Despite challenging macroeconomic conditions, the company generated positive cash flow from operations of $600,000. The shift towards online channels contributed 76% of revenues, increasing from 68% in the prior year's quarter. Lab-grown diamond sales surged by 19% compared to last year, with a 603% year-to-date increase since 2021. The company maintains a healthy cash position of $17 million, with no debt, but reported a net loss of $1 million for the quarter.
Charles & Colvard, Ltd. (NASDAQ: CTHR) has announced an investor conference call scheduled for February 2, 2023, at 4:30 p.m. ET to discuss its financial results for the second quarter of fiscal year 2023, ending on December 31, 2022. The financial results will be released after market close on the same day. Interested parties can access the call by dialing (844) 875-6912 (U.S.) or through the live webcast available on the Company’s website. Replay options will be available until February 9, 2023.
Charles & Colvard, Ltd. (Nasdaq: CTHR) has partnered with Lytham Partners, a leading investor relations firm, to enhance its shareholder communication strategy. The collaboration aims to refine the company’s messaging, broaden its investor base, and implement best practices in investor communications as it enters a new growth phase. Lytham Partners has over 20 years of experience and a substantial network within the investment community, which will benefit Charles & Colvard by providing better exposure to institutional investors. The company is known for its ethical jewelry, primarily focusing on lab-grown gemstones and recycled precious metals.
Charles & Colvard (CTHR) reported net sales of $7.4 million for Q1 Fiscal 2023, down 28% year-over-year. Highlights include a 85% surge in lab-grown diamond sales, but a 12% decline in moissanite sales. The company opened its first retail showroom in October and launched new collections, emphasizing strategic investments to appeal to conscious consumers. Operating expenses rose 5% to $4.5 million, while cash and equivalents stood at $16.6 million. The net loss was $890,000, equating to $0.03 per diluted share.
Charles & Colvard, Ltd. (Nasdaq: CTHR) will host an investor conference call on November 3, 2022, at 4:30 p.m. ET to discuss its financial results for Q1 Fiscal Year 2023, ending September 30, 2022. The results will be released after market close on the same day. Investors can join the call via telephone or webcast, with a replay available until November 10, 2022. Charles & Colvard is known for its lab-created gemstones, including its Forever One™ moissanite brand and Caydia® lab-grown diamonds.